An exon 10 deletion in the mouse ferrochelatase gene has a dominant-negative effect and causes mild protoporphyria

Blood

Volumn 100, Issue 4, 2002, Pages 1470-1477

  Magness, Scott T ^a   Maeda, Nobuyo ^a   Brenner, David A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERROCHELATASE; IRON; IRON CHELATING AGENT; MESSENGER RNA; PROTEIN; PROTOPORPHYRIN;

ANIMAL CELL; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BILE; CELL HETEROGENEITY; CONTROLLED STUDY; CROSSING OVER; DISEASE SEVERITY; EMBRYOTOXICITY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME DEFICIENCY; ERYTHROCYTE KINETICS; ERYTHROPOIETIC PROTOPORPHYRIA; EXON; GENE DELETION; GENE MUTATION; GENE TARGETING; GENETIC DISORDER; GENOTYPE; HETEROZYGOTE; IMMUNOREACTIVITY; IRON CHELATION; LIVER DISEASE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA ANALYSIS;

EID: 0037103294     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2001-12-0283     Document Type: Article

References (67)

1. Structure of the human ferrochelatase gene: Exon/intron gene organization and localization of the gene to chromosome 18
2. Cloning of murine ferrochelatase
3. Structure and transcriptional regulation of the mouse ferrochelatase gene
4. Deletion of the ferrochelatase gene in a patient with protoporphyria
5. Function of the [2FE-2S] cluster in mammalian ferrochelatase: A possible role as a nitric oxide sensor
6. Spectroscopic examination of the active site of bovine ferrochelatase
7. Orientation of ferrochelatase in bovine liver mitochondria
8. The functional size of ferrochelatase determined in situ by radiation inactivation
9. Human ferrochelatase: Crystallization, characterization of the [2Fe-2S] cluster and determination that the enzyme is a homodimer
10. The 2.0 A structure of human ferrochelatase, the terminal enzyme of heme biosynthesis
11. Study of factors causing excess protoporphyrin accumulation in cultured skin fibroblasts from patients with protoporphyria
12. Liver transplantation in a patient with protoporphyria
13. Erythropoetic protoporphyria: A new porphyria syndrome with solar urticaria due to protoporphyrinaemia
14. Hepatic disease in erythropoietic protoporphyria
15. Heme synthesis in protoporphyria
16. Erythropoietic protoporphyria: Lipid peroxidation and red cell membrane damage associated with photohemolysis
17. Molecular and cellular mechanisms of porphyrin photosensitization
18. Enterohepatic circulation and conversion of protoporphyrin to bile pigment in man
19. Interaction of hemopexin, albumin and liver fatty acid-binding protein with protoporphyrin
20. Pathogenesis and therapy of liver disease in protoporphyria
21. Evidence that hepatic crystalline deposits in a patient with protoporphyria are composed of protoporphyrin
22. The liver and protoporphyria
23. Beta carotene therapy for erythropoietic protoporphyria and other photosensitivity diseases
24. Diagnosis and treatment of erythropoietic protoporphyria
25. Iron therapy for hepatic dysfunction in erythropoietic protoporphyria
26. Liver transplantation for protoporphyria. Evidence for the predominant role of the erythropoietic tissue in protoporphyrin overproduction
27. The effect of liver transplantation in a 13-year old boy with erythropoietic protoporphyria
28. Follow-up after liver transplantation for protoporphyric liver disease
29. Long-term follow-up after liver transplantation for erythropoietic protoporphyria
30. Reversion of hepatobiliary alterations By bone marrow transplantation in a murine model of erythropoietic protoporphyria
31. Long-term cure of the photosensitivity of murine erythropoietic protoporphyria by preselective gene therapy
32. Successful therapeutic effect in a mouse model of erythropoietic protoporphyria by partial genetic correction and fluorescence-based selection of hematopoietic cells
33. Human erythropoietic protoporphyria: Two point mutations in the ferrochelatase gene
34. Recessive inheritance of erythropoietic protoporphyria with liver failure
35. Recessive inheritance of erythropoietic protoporphyria with liver failure
36. Systematic analysis of molecular defects in the ferrochelatase gene from patients with erythropoietic protoporphyria
37. A molecular defect in human protoporphyria
38. Genetic aspects of erythropoietic protoporphyria
39. Modulation of the phenotype in dominant erythropoietic protoporphyria
40. A novel mutation in erythropoietic protoporphyria: An aberrant ferrochelatase mRNA caused by exon skipping during RNA splicing
41. Systematic screening for RNA with skipped exons - Splicing mutations of the ferrochelatase gene
42. Screening for ferrochelatase mutations: Molecular heterogeneity of erythropoietic protoporphyria
43. Autosomal recessive erythropoietic protoporphyria: A syndrome of severe photosensitivity and liver failure
44. New insights into the pathogenesis of erythropoietic protoporphyria and their impact on patient care
45. Examination of ferrochelatase mutations that cause erythropoietic protoporphyria
46. Mutations in the iron-sulfur cluster ligands of the human ferrochelatase lead to erythropoietic protoporphyria
47. Targeted disruption of the mouse ferrochelatase gene producing an exon 10 deletion
48. Single-copy transgenic mice with chosen-site integration
49. Hematopoiesis in the embryonic mouse spleen, II: Alterations after phenylhydrazine administration to the mothers
50. Morphological investigation on phenylhydrazine-induced erythropoiesis in the adult mouse liver
51. Extraction, purification and analysis of mRNA from eukaryotic cells
52. Ferrochelatase cDNA delivered by adenoviral vector corrects biochemical deficiency in protoporphyric cells
53. Tissue porphyrin pattern determination by high-speed high-performance liquid chromatography
54. Separation of porphyrin isomers by high-performance liquid chromatography
55. Erythropoietic protoporphyria: Treatment with antioxidants and potential cure with gene therapy
56. Long-term cure of the photosensitivity of murine erythropoietic protoporphyria by preselective gene therapy
57. Erythropoietic protoporphyria: Clinical aspects with emphasis on the skin
58. Birefringence of hepatic pigment deposits in erythropoietic protoporphyria. Specificity of polarization microscopy in the identification of hepatic protoporphyrin deposits
59. Gross, microscopic and ultrastructural lesions of protoporphyria in Limousin calves
60. Mouse model for protoporphyria, I: The liver and hepatic protoporphyrin crystals
61. Hepatobiliary implications and complications in protoporphyria, a 20-year study
62. Hepatic and bile porphyrins in patients with protoporphyria and liver failure
63. Erythropoietic protoporphyria in the house mouse. A recessive inherited ferrochelatase deficiency with anemia, photosensitivity, and liver disease
64. Ferrochelatase structural mutant (Fechm1Pas) in the house mouse
65. Inheritance in erythropoietic protoporphyria: A common wild-type ferrochelatase allelic variant with low expression accounts for clinical manifestation
66. The penetrance of dominant erythropoietic protoporphyria is modulated by expression of wildtype FECH